Health Condition 1: L649- Androgenic alopecia, unspecified
Conditions
Interventions
Intervention1: Cuticapil Stem Hair Serum: 2% Minoxidil Monotherapy or with 2% Minoxidil therapy and Cuticapil Stem (Purmed water, caffeine, herbasome, Zemea propandiol, procapil, DC 193 C, Capilia Lon
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Male or female patients of 18 or above with diagnosis of hair loss Hair shedding > 6 month Clinical diagnosis of male AGA Grade III, Grade IV, Grade V and clinical diagnosis of FPHL Grade II and Grade III naïve cases or treated with 5% Minoxidil. Patients with no known allergy. Patients who agree to refrain from using hair dye, oil treatment or spa treatment, perming or straightening during the treatment/observation period Patients who agree to use Non ketoconazole based shampoo
Exclusion criteria
Exclusion criteria: Cosmetic hair treatments 1 month prior to enrolment Patients with Hemoglobin level below 10.5 Patients with thyroid disorders or other systemic disorders including T2DM, Hypertension, HIV, Hepatitis, Anemia, Heart disorders, Cancer & undergone chemotherapy, Depression, any psychiatric disorders and those taking drugs which could cause alopecia Pregnant and lactating females Patients with scalp disease Heavy Smokers & heavy drinkers Patients on crash diets
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in hair count shedding after shampooing from baseline at 10 weeks. Change in hair count with Pull test from baseline at 10 weeks. Global photography assessment at 10 week as centrally adjudicated scale score for hair count.Timepoint: at 10 week | — |
Secondary
| Measure | Time frame |
|---|---|
| Safety assessment of the hair serum AGA, FPHL, Patient Global Assessment Timepoint: At 10 week | — |
Countries
India
Contacts
Public ContactDr Rathish Nair PhD MBA
Torrent Pharmaceuticals Ltd
Outcome results
None listed